Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orange Grove Bio
Cincinnati, Ohio, United Statesorangegrovebio.com ↗
- Ownership
- Private
- Employees
- ~34
- Development stage
- Preclinical
01
Overview
Preservation Bio’s novel additive extends refrigerated platelet storage up to 14 days with improved safety profile demonstrated in preclinical studies. Phase 1 clinical trials planned at Hoxworth Blood Center and American Red Cross focusing on platelet survival/recovery endpoints. Genexys awarded NIH SBIR grant supporting advancement of cystic fibrosis gene therapy program from preclinical toward IND-enabling studies
- Therapeutic areas
- OncologyPulmonologyImmunologyHematology
- Modalities
- Novel genetic medicinesNon-viral gene therapy platformsBiologics (immune modulation)Ex vivo biologic additivePlatelet preservation technologies
- Industry
- Biotech
02
Partnerships
University of Cincinnati College of MedicineWeizmann Institute of Science
Beyond the preview
Go deeper on Orange Grove Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Orange Grove Bio.